Acellular dermal substitute use in the reconstruction of axillary hidradenitis suppurativa. (March 2022)

• Record Type: Journal Article
• Authors: Dhannoon, A.; Hurley, C.M.; Carr, S.; Hussey, A.
• Is Part Of: JPRAS open. Volume 31(2022)
• Page Start: 129
• Page End: 133
• Publication Date: 2022-03
• Subjects: Hidradenitis Suppurativa -- Axillary -- Matriderm® -- Acellular -- Skin substitute; Surgery, Plastic -- Great Britain -- Periodicals; 617.9505
• DOI: 10.1016/j.jpra.2021.11.003
• Languages: English
• ISSNs: 2352-5878

Abstract

Abstract: Hidradenitis suppurativa (HS) is a chronic recurrent debilitating condition that affects the skin near to the follicular glands. The disease manifests with the formation of abscesses that can be complicated by rupture, sinus tracts, and scarring leading to pain, chronic discharge, malodor, and scar contractures. The management of HS is multidisciplinary, involving general lifestyle modification, medical treatment, and surgery. A wide range of surgical interventions has been described for HS disease control and management. However, surgical management strategies are highly variable. We describe the case of a 33-year-old female with refractory HS which was reconstructed with Matriderm® and an immediate split-thickness skin graft. Acellular dermal skin substitutes may be an alternative to conventional means of HS reconstruction, producing subtle, pliable, and durable skin.